Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson's disease

Yang, XY; Feng, P; Ji, R; Ren, YQ; Wei, WS; Holscher, C

Ren, YQ; Wei, WS (通讯作者)，Fudan Univ, Dept Neurol, Huadong Hosp, 221 West Yanan Rd, Shanghai, Peoples R China.

EXPERT OPINION ON THERAPEUTIC TARGETS, 2022; 26 (5): 445

Abstract

Introduction Diabetes is a risk factor for Parkinson's disease (PD) and shares similar dysregulated insulin pathways. Glucagon-like peptide-1 (GLP-1) ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索